Related Experiment Videos

In vitro activity of protoanemonin, an antifungal agent

M L Martín1, L San Román, A Domínguez

  • 1Departamento de Fisiologia y Farmacología, Universidad de Salamanca, Spain.

Planta Medica
|February 1, 1990
PubMed

Insights

Protoanemonin, a compound from Pulsatilla alpina, shows antifungal activity by inhibiting RNA. Its effectiveness is demonstrated by a minimum inhibitory concentration (MIC) of 15 µg/mL and a median lethal dose (LD50) of 190 mg/kg in mice.

Area of Science:

  • Pharmacology
  • Mycology
  • Natural Products Chemistry

Background:

  • Pulsatilla alpina is a plant source of bioactive compounds.
  • Fungal infections pose a significant health challenge.
  • Understanding novel antifungal agents is crucial.

Purpose of the Study:

  • To investigate the in vitro antifungal activity of protoanemonin.
  • To determine the primary molecular target of protoanemonin.
  • To assess the acute toxicity of protoanemonin.

Main Methods:

  • Isolation of protoanemonin from Pulsatilla alpina.
  • Determination of minimum inhibitory concentration (MIC) against fungi.
  • Assessment of RNA inhibition as a potential mechanism of action.
  • Median lethal dose (LD50) determination in male Swiss albino mice.

Main Results:

  • Protoanemonin demonstrated in vitro antifungal activity.
  • The minimum inhibitory concentration (MIC) was determined to be 15 µg/mL.
  • RNA inhibition was identified as a likely primary target of protoanemonin.
  • The median lethal dose (LD50) in male Swiss albino mice was 190 mg/kg.

Conclusions:

  • Protoanemonin exhibits promising in vitro antifungal properties.
  • RNA inhibition is a key mechanism underlying protoanemonin's antifungal effects.
  • Protoanemonin possesses moderate acute toxicity in mice, requiring further safety evaluations.

Related Concept Videos